The long-anticipated merger between Germany's leading mRNA developers is now official. BioNTech SE announced late Wednesday ...

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...

With just under a month left to go in 2025, 12 members of the S&P 500 SPX have seen their stocks drop more than 40% this year. The weakest stock of the bunch, Fiserv (FISV), has declined nearly 70%.

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief ...

Moderna has continued to underperform the Nasdaq Composite over the past year, and analysts remain cautious about the stock’s ...

Moderna recently faced pressure after the U.S. Food and Drug Administration announced plans to require more rigorous safety ...

Pfizer's concerted effort to move beyond its pandemic-era business and establish a new growth foundation in oncology faced an unexpected challenge this week. A revelation concerning regulatory ...

Shares of Moderna and BioNTech fell on Monday, likely in response to a FDA official's memo outlining a link between COVID-19 mRNA vaccines and myocarditis deaths in 10 children. Concern about that ...

Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...

Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...

Major U.S. equities indexes lost ground Monday afternoon, as shares of tech and cryptocurrency-related companies pulled back.

Shares of Moderna, Inc. (NASDAQ:MRNA) are trading lower Monday following reports suggesting tighter controls on how vaccines gain approval.